The Alcohol Center for Translational Genetics (ACTG) will have two major themes. The first will be to study novel proteins to determine whether they or the signaling pathways in which they participate contain potential drug targets for treating alcohol use disorders. The other main theme of the ACTG will be to investigate whether the genes that encode these proteins are associated with risk of alcoholism in humans. The proteins and signaling pathways in which they participate will be chosen from ongoing invertebrate genetic screens or ex vivo and in vitro studies. The approach is based on the intriguing hypothesis that genes identified in these model systems have relevance for human alcoholism. This hypothesis has been validated, in part, by studies demonstrating the importance of PKA- and PKC-mediated signaling, and specific peptides and ion channels in behavioral responses to alcohol in invertebrates, cultured neural cells and rodents. Candidate proteins will be validated in rat and mouse behavioral models that measure either the level of response to acute ethanol exposure or drug self-administration and reward. Allelic variants in humans will be identified that are predicted to alter gene expression or protein function and confer risk of alcoholism in humans. Four research components, four core components, and a pilot project component address these themes. Three research projects will focus on intensively studying genes novel to the alcohol research community in mice and rats: H-Ras (Component 5), munc-79 (Component 6), and Tao kinases (Component 7). A fourth research project (Component 8) will identify variants of these and related genes in humans and, perform studies to examine their functional significance. In addition to an Administrative Core (Component 1) to manage ACTG functions, there will be three Scientific Cores. An Animal and Behavior Core (Component 2) will establish a standardized battery of behavioral studies for all research projects using mice, and will provide mouse breeding and genotyping services and assistance with complex behavioral studies for the ACTG. A Transgenic and Imaging Core (Component 3) will provide state-of-the art services for generating gene-targeted mice and viral vectors for expression of transgenes or gene silencing by RNA interference in rats and mice. A Genomics core (Component 4) will provide high-throughput sequencing capability, bioinformatics tools and support, and assistance with quantitative RT-PCR. Two Pilot projects will perform early studies of novel proteins and pathways involving atypical protein kinase C isozymes in rats, a Drosophila MAP kinase phosphatase, and a Drosophila BMP2/4 homolog. Collectively, the ACTG will provide a unique center for the detailed study across species of novel genes that may lead to the development of new approaches for preventing and treating alcohol use disorders in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Specialized Center (P50)
Project #
5P50AA017072-05
Application #
8353330
Study Section
Special Emphasis Panel (ZAA1-BB (11))
Program Officer
Reilly, Matthew
Project Start
2008-05-20
Project End
2013-06-30
Budget Start
2012-05-01
Budget End
2013-06-30
Support Year
5
Fiscal Year
2012
Total Cost
$1,338,794
Indirect Cost
$536,160
Name
Ernest Gallo Clinic and Research Center
Department
Type
DUNS #
173995366
City
Emeryville
State
CA
Country
United States
Zip Code
94608
Wegner, Scott A; Pollard, Katherine A; Kharazia, Viktor et al. (2017) Limited Excessive Voluntary Alcohol Drinking Leads to Liver Dysfunction in Mice. Alcohol Clin Exp Res 41:345-358
Morisot, N; Ron, D (2017) Alcohol-dependent molecular adaptations of the NMDA receptor system. Genes Brain Behav 16:139-148
Rinetti-Vargas, Gina; Phamluong, Khanhky; Ron, Dorit et al. (2017) Periadolescent Maturation of GABAergic Hyperpolarization at the Axon Initial Segment. Cell Rep 20:21-29
Liu, F; Laguesse, S; Legastelois, R et al. (2017) mTORC1-dependent translation of collapsin response mediator protein-2 drives neuroadaptations underlying excessive alcohol-drinking behaviors. Mol Psychiatry 22:89-101
Hopf, F W (2017) Do specific NMDA receptor subunits act as gateways for addictive behaviors? Genes Brain Behav 16:118-138
Blasio, Angelo; Wang, Jingyi; Wang, Dan et al. (2017) Novel Small-Molecule Inhibitors of Protein Kinase C Epsilon Reduce Ethanol Consumption in Mice. Biol Psychiatry :
Phamluong, Khanhky; Darcq, Emmanuel; Wu, Su et al. (2017) Fyn Signaling Is Compartmentalized to Dopamine D1 Receptor Expressing Neurons in the Dorsal Medial Striatum. Front Mol Neurosci 10:273
Laguesse, Sophie; Morisot, Nadege; Phamluong, Khanhky et al. (2017) Region specific activation of the AKT and mTORC1 pathway in response to excessive alcohol intake in rodents. Addict Biol 22:1856-1869
Fan, QiWen; Aksoy, Ozlem; Wong, Robyn A et al. (2017) A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma. Cancer Cell 31:424-435
Yang, Sungchil; Ben-Shalom, Roy; Ahn, Misol et al. (2016) ?-Arrestin-Dependent Dopaminergic Regulation of Calcium Channel Activity in the Axon Initial Segment. Cell Rep 16:1518-1526

Showing the most recent 10 out of 66 publications